<DOC>
	<DOCNO>NCT00740441</DOCNO>
	<brief_summary>The aim study evaluate efficacy AS1411 patient Metastatic Renal Cell Carcinoma</brief_summary>
	<brief_title>A Phase II Study AS1411 Renal Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Histologically cytologically confirm renal cell carcinoma contain predominant clear cell histology Failed intolerant 1 previous line treatment ( must include Tyrosine Kinase Inhibitor ) Collecting duct histology A history bleed disorder currently take oral vitamin K antagonise medication Unstable brain metastasis History prior concomitant malignancy ( except curatively treat nonmelanoma skin cancer carcinoma situ cervix , cancer patient disease free 3 year )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>renal cell carcinoma</keyword>
	<keyword>rcc</keyword>
	<keyword>kidney cancer</keyword>
</DOC>